tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Technical Analysis

1,478 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Coherus Biosciences is a Buy.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 1.46, while Coherus Biosciences’s (CHRS) share price is $1.52, making it a Buy.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 1.27, while Coherus Biosciences’s (CHRS) share price is $1.52, making it a Buy.

Coherus Biosciences (CHRS) Pivot Points

Dec 21, 2024, 04:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.27
1.36
1.42
1.51
1.57
1.66
1.72
Fibonacci
1.36
1.42
1.45
1.51
1.57
1.60
1.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Dec 21, 2024, 04:52 PM
Period
Simple
Exponential
MA5
1.60Sell
1.56Sell
MA10
1.60Sell
1.56Sell
MA20
1.51Buy
1.46Buy
MA50
1.10Buy
1.27Buy
MA100
1.16Buy
1.29Buy
MA200
1.56Sell
1.61Sell
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 1.56, while Coherus Biosciences’s (CHRS) share price is $1.52, making it a Sell.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 1.29, while Coherus Biosciences’s (CHRS) share price is $1.52, making it a Buy.
Coherus Biosciences’s (CHRS) stock price is $1.52 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 1.10, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.52 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 1.16, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.52 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 1.56, creating a Sell signal.

Coherus Biosciences (CHRS) Technical Indicators

Dec 21, 2024, 04:52 PM
Name
Value
Implied Action
RSI (14)
55.95
Neutral
STOCH (9,6)
23.93
Neutral
STOCHRSI (14)
20.88
Neutral
MACD (12,26)
0.14
Buy
ADX (14)
46.12
Neutral
Williams %R
-88.35
Buy
CCI (14)
-14.65
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
45.45
Neutral
ROC
10.95
Buy
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 55.95, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 46.12, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is -14.65, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is 10.95, creating a Buy signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Hold.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 55.95, which suggests CHRS is a Neutral.
      What is CHRS’s MACD?
      CHRS’s MACD is 0.14, which suggests CHRS is a Buy.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 1.60, which suggests CHRS is a Sell.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 1.51, which suggests CHRS is a Buy.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 1.10, which suggests CHRS is a Buy.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 1.56, which suggests CHRS is a Sell.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -88.35, which suggests CHRS is a Buy.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is -14.65, which suggests CHRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis